Amsterdam,
12
March
2018
|
16:01
Europe/Amsterdam

Start of Ground-breaking Research into New Type of Light Therapy for Skin Diseases

Light-emitting Nanomaterials Should Alleviate Skin Conditions Like Psoriasis

Summary

The Amsterdam R&D company Seaborough has been awarded a grant to develop new nanomaterials that can be used for safer and more effective UVB light therapy treatments for skin conditions. The CHIPP grant provided by the Netherlands Organization for Scientific Research (NWO) is intended for public-private partnerships, in this case Seaborough together with Utrecht University and the University of Groningen. The new materials prevent healthy skin from receiving an overdose of UV radiation, which is currently a limiting factor in the effectiveness of light therapy and involves high safety risks.

The nanomaterials to be developed help to relieve the complaints of skin diseases more quickly and with fewer treatments, and also make it easier to carry out the treatments safely at home. This would be a great help to patients with skin condition (e.g. eczema and psoriasis).

Co-investors Needed for Practical ApplicationMartijn Dekker, CEO of Seaborough, explains, "Light therapy is a treatment method that has long been applied within dermatology, as it is highly effective and has few side effects. However, light therapy is not always preferred by doctors or patients, because treatments take a lot of time, must be repeated often, and have to be given at the hospital. We now want to see if we can offer a much cheaper and faster solution with the help of advanced optical materials, which can also be used at home in consultation with the doctor. Naturally, we would also like our medical application to be transformed into a product. If we want to achieve this, we have to find co-investors and partners with specific knowledge of the medical market."